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E V I D E N C E - B A S E D A N S W E R
Reassure patients that their condition 
is real and treatable
The care of patients with fibromyalgia can be
very challenging. An important component of 
successful management of these patients’ condition
is helping them realize that we, as physicians,
believe that their pain is real. It is important to
reassure them that even though fibromyalgia is not
curable, it is treatable and is not a life-threatening
condition. Based on expert opinion, combining 
2 or more of treatments with the best supporting
evidence for effectiveness seems to be the most
successful approach to the management of
fibromyalgia syndrome.
There is no single most effective modality for 
the treatment of fibromyalgia syndrome, and no
objective comparison of the results from the 
different studies is available. Low-dose tricyclic
antidepressants (TCAs) improve sleep quality and
global well-being and have a moderate beneficial
effect on tenderness and stiffness (strength of 
recommendation [SOR]: A, based on a systematic
review of randomized controlled trials [RCTs]). 
Selective serotonin reuptake inhibitors (SSRIs)
may moderately improve fibromyalgia-related
symptoms (SOR: B, based on a few RCTs). The
serotonin and norepinephrine reuptake inhibitors
(SNRIs) duloxetine (Cymbalta) and milnacipran
(Ixel, not currently available in the US) 
improve pain and other symptoms (SOR: B, 
based on single RCTs). Tramadol (Ultram)
improves pain and other outcomes (SOR: A,
based on a few RCTs). Cyclobenzaprine 
(Flexeril) improves both pain and sleep quality
(SOR: A, based on a systematic review 
of RCTs). 
Aerobic exercise improves overall functional
capacity and sense of well-being for patients 
with fibromyalgia (SOR: A, based on a systematic
review of RCT). Cognitive behavioral therapy
improves patients’ self-reported symptoms 
(SOR: A, based on RCTs). 
C L I N I C A L C O M M E N T A R Y
■ Evidence summary
Evidence supporting the effectiveness of
TCAs is strong, especially amitriptyline, in
fibromyalgia-related symptoms. A meta-
analysis that included 10 trials of low-dose
TCAs (eg, 25–50 mg of amitriptyline)
showed moderate improvement in sleep,
pain, fatigue, and overall well-being 
(number needed to treat [NNT] for
improvement=4).1 A meta-analysis of 5
RCTs on cyclobenzaprine, a muscle relax-
ant chemically related to TCAs, demon-
strated its effect in improving pain and
sleep disturbance (NNT=5).2
There is less evidence that other med-
ications are effective. Two of 3 RCTs of 
fluoxetine (Prozac) have shown that it was
more effective than placebo, and 2 RCTs
have shown that fluoxetine and sertraline
(Zoloft) are comparable to amitriptyline.3
Single RCTs conducted on duloxetine and
milnacipran, new SNRIs, demonstrated
them to be more effective than placebo in
improving pain and scores on the
Fibromyalgia Impact Questionnaire (FIQ).3
Three RCTs have shown that tramadol
(with or without acetaminophen) is more
effective than placebo in improving pain,
number of tender points and FIQ score.3
A single RCT has demonstrated that 
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pregabalin (Lyrica), a new anticonvulsant,
reduces pain more than placebo.3
Among nonpharmacological interven-
tions, aerobic exercise and cognitive behav-
ioral therapy have the strongest evidence of
effectiveness. A systematic review assessing
various exercise programs on symptoms of
fibromyalgia showed that aerobic exercise
produces short-term improvements in 
cardiovascular fitness, tender-point pres-
sure pain threshold, and patient- and physi-
cian-rated global well-being. Three of these
trials included long-term follow-up of the
exercise group participants. Patients who
continued exercising maintained their
improved physical functioning.4
Cognitive behavioral therapy has been
shown to reduce symptoms in 5 RCTs.3
Combining cognitive behavioral therapy
with education and exercise has also been
effective in 5 additional RCTs.3 Some evi-
dence suggests that acupuncture, massage,
warm baths, and biofeedback are effective,
but this is limited because of methodologi-
cal issues in the studies that have been 
conducted to date.3
Recommendations from others
A recently published evidence-based guide-
line sponsored by the American Pain
Society recommends low-dose TCAs,
cyclobenzaprine, cardiovascular exercise,
and cognitive behavioral therapy alone or
with exercise as first-line therapy along
with patient education and treatment of
comorbid conditions. For patients that do
not improve, it recommends a trial of an
SSRI, an SNRI, tramadol, an anticonvul-
sant, combination medications, or referral.3
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C O R R E C T I O N
■ A sentence was omitted from a Clinical Inquiry published in
March (Scott S, Porter M, Quadri Y. How should we follow
up a positive screen for anemia in a 1-year old? J Fam Pract
2005 Mar; 54(3): 272, 275–276). The first paragraph should
have read (omitted sentence in boldface):
Healthy infants who test positive for anemia on rou-
tine screening at one year of age are most likely iron
deficient and may be treated with an empiric trial of
iron therapy (3–6 mg of elemental iron/kg/day); docu-
mentation of response to iron confirms the diagnosis of
iron-deficiency (SOR: B; evidence from randomized
controlled trials with some conflicting results; lack of
evidence for long-term benefits/harms of screening
strategies). Further work-up for causes of anemia
should be reserved for infants who do not respond to
iron replacement. In these cases, further testing with a
complete blood count (CBC), mean corpuscular vol-
ume (MCV), red cell distribution width (RDW) and
serum ferritin concentration may be effective in deter-
mining the cause of anemia (SOR: C; expert opinion). 
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